ArticleCell death & disease2026

Targeting glycerophospholipid biosynthesis overcomes chemoresistance driven by SLFN11 loss in Ewing sarcoma.

Kasturee Chakraborty et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.